This paper is dedicated to Professor MichelP feffer (ULP,S trasbourg) for his contributions to C À Ha ctivation and palladacycle chemistry.
Introduction
Then eedf or efficiency in rapidlyp roducing al ibrary of closely related analogues cannot be understated in drug discovery where natural product derivatives or complexm olecules,o ften synthesised by multistep reactions,a re fine-tuned to respond to inadequacies in terms of their biological activity,s electivity,p harmacokineticsa nd undesirablet oxicity.T he ability to add functionality to ab ioactive core at the finalo rp enultimate synthetic step to enable SAR (structure-activity relationship) studies can drive efficiency and speed up hit-to-lead and leadoptimisation strategies. [1] We have alongstanding interest in benzodiazepines, which represent an important class of privileged heterocycles. [2] Ty pical routes for the introduction of different Rg roups at the 5-position are inefficients ince such reactions are earlyi nt he synthetic sequence and this is followed by repetitive coupling/cyclisation chemistries (Scheme 1).
Scheme1.Ac lassical route to a5 -(2-arylphenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one.
Results and Discussion
Our approach sought to vary the 5-substituent via al ate-stage C À Ha ctivation;i ne ssence,abenzodiazepine building block could be synthesised, once,o n al arge scale using the coupling/cyclisation chemistry discusseda bove,t hen functionalised by introducing the new functional groups at the last step, adding atom ands tep economy [3] to the library generation process.O ur test case was the chelation-assisted C À H activation of the valium (diazepam)-like benzodiazepine 1a using palladacycle chemistry to afford 2a ( Table 1 ). [4] Notably,C intrat et al. showedt hat orthohalogenation [4c] of the aryl group can be achieved under similar conditions,o pening up the possibility of carrying out complementary Pd-mediated couplings. Ar apid screen of conditions showedt hat this was indeed possible and that the best conversions,b y 1 HNMR, involved acetic acid as solvent, microwave conditions, [5] andemployed 5mol% Pd(OAc) 2 as catalyst and Ph 2 IBF 4 [6] as the arylating agent (entry 2). Theu se of am esityl-aryliodoniums alt gaves imilar promising results (entry 4) andw ill be exploited further on (vide infra). Further iterations ( Table 2 ), including the use of classical, thermal conditions,l ower Pd loadings,a dditives such as silver salts, [7] led to no or little improvement,a lthoughh igher concentrations of reagents led to slightly improved conversions (entry 9, Table2).
Using our "optimised" approach we synthesised ar ange of benzodiazepines via this last-stage C À Ha ctivationp rotocol. Critically,w ew ere able to confirm that the C À Ha ctivation hado ccurred in the ortho-position as anticipatedf rom ac helation controlled process by crystal-structure determinations of an umber of products( vide infra) [8] (Figure 1 ). We synthesised as eries of fluorinated aromatics 2 due to the advantageousrole of fluorine in medicinalc hemistry. [9] At this stage,w ew ere stills omewhat dissatisfied with this approach since we were confined to an N-1m ethyl substituent in the final product.Abroader diversity would be enabled by having aN -protected or freea mide group,e nabling furtherd iversification after the arylation reaction. To test the more attractive latter hypothesis,p reliminary studies on the C À H activation process were carriedo ut (Scheme 2) and established that:
(i)S toichiometric chelation-assisted C À Ha ctivation is indeed possible on the unsubstituted N À H amide since the palladacycle 3 can be isolated. (ii)A na ttempted interception of the palladacycle intermediate,b yaPd-catalyzed H/D exchange, [10] did not lead to the expected product 1c.I nstead, this reaction, furnishedu niquely the D 2 -methylene compound 1d,w hich could also be accomplished in the absence of the metal catalyst by merely stirring in deuterated acetic acid in the microwave,s imilar to previousf indings on H/D exchange. [11] [a] All reactions were conducted in aCEM Explorer microwave unless stated otherwise. [b] Conventional heating.
[c] Analysis of the crude mixture,after PPh 3 treatment, showed evidence that the palladacycle was formed.
[d] Ag 2 Oadded (1.5 equiv.).
[e] Ag 2 Oadded (1.5 equiv.at1 00 8 8C).
[f] AgOAc added (1.5 equiv.at1 00 8 8C).
[g] AcOH degassed,r eaction under N 2 .
[h] AcOH dry and degassed, reaction underN 2 . Next, we produced al ibrary of benzodiazepines lacking an N-1 substituent( Figure 2 ). Of note,w e were also able to produce arylatedn ordazepam [12] derivatives 5;n ordazepam was quickly made by an adaptation of am icrowave protocol. [13] Yields,i ng eneral, were superior to those for their N-methylated analogues, mainly with electron-poor arenes, whereas the electron-rich 4f and 4h were made in moderate yield (note: the 2-tolyld erivative of 4h did not form, possibly due to sterice ffects). We were pleasantly surprisedt ob ea blet oo btain the hindered 4g,a lbeit under more forcingm icrowave conditions.A nalogue 5b was madef rom am esityl-containing aryliodonium salt.
Products were separated initially using am ass-triggered LC-MS protocol [14] but we found that ar eversed-phase LC-MSm ethod was equally useful and we were also able to recover traces of unreacteds tarting material. Moreover, diarylated productsw ere often observedi nt he crude reactionm ixtures and, in some cases,w ere isolated (Scheme 3, for example, 5c' ', 5d' ').T he yields of 5d and 5d' ' were rather low,e ven when using ahigher temperature.
Following our earlier studies (Scheme 2), we prepared as mall number of deuterated derivatives 6a-6c (Scheme 4). Compound 6a,t he deuterated analogue of 5c,w as prepared by ao ne-pot dual C À Ha ctivation/H-Dexchangebysimply carrying out the catalytic arylation protocol in CD 3 CO 2 Dw hereas 6b, 6c (and earlier, 1b)w ere simplyp reparedb ys tirring the arylatedprecursors in CD 3 CO 2 Di namicrowave.
Deuterated benzodiazepine productsw eree asily characterized, for example,b y 2 HNMR (see the Sup-porting Information, note:N Dt ends to revert to NH when the samples are concentrated in air).
Af urther illustration of the diversity achievable is that the resulting elaborated nordazepam derivatives 5 can be N-alkylated to afford substituted diazepam and pinazepam analogues( Figure 3 ).
Conclusions
In summary,w eh aves ynthesized al ibrary of benzodiazepines via al ate stage C À Ha ctivation reaction. Studies are now underwayt oa ddress the drug-likeness of the productsb yf or example,l owering their clogP,t esting their biological activity,a sw ell as applying this chemistry to other systems related to benzodiazepinessuch as benzotriazepines. [15] Experimental Section
General Information
All commercially purchased materials and solvents were used without further purification unless specified otherwise. NMR spectra were recorded on aV arian VNMRS 500 ( 13 Cc hemical shifts were recorded in parts per million (ppm). Multiplicity of 1 HNMR peaks are indicated by ssinglet,d-d oublet, dd -d oublets of doublets,t-t riplet, pt -p seudo triplet, q-quartet, m-multiplet and coupling constants are given in Hertz (Hz) . Electron spray ionisationhigh resolution mass spectra (ESI-HR-MS) were obtained using aB rukerD altonics Apex III whereA pollo ESI was used as the ESI source.A ll analyses were conducted by Dr. A. K. Abdul-Sada. Them olecular ion peaks [M] + + were recorded in mass to charge (m/z)r atio.
LC-mass spectra were acquired using aS himadzu LC-MS 2020, on aG emini 5mC18 110 . column. All X-ray analyses were performed att he UK National Crystallography Services,S outhampton. All elemental analyses were carried out at the Elemental Analysis Service,L ondon Metropolitan University.P urifications were performed by flashc hromatography on silica gel columns or C18 columns using aCombi flash RF 75 PSI, ISCO unit. CCDC 1422838, 1422839, 1422840, 1422841, 1422842, 1422843 and CCDC 1422844 contain the supplementary crystallographic data for this paper. Thesed ata can be obtained free of charge from TheC ambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 6 Hz, 1H), 7.22 (pt, J = 7.9 Hz, 1H), 7.09-6.98( m, 3H), 6.92-6.82 (m, 5H), 3.13 (s,3 H); 13 CNMR (126 MHz, CDCl 3 ): d = 173. 2, 169.4, 142.9,1 42.2, 138.4, 131.2, 130.5, 130.2, 130 .0,1 29.9, 129.2,1 28.7 (2 C), 127.7 (2 C),1 27. 5, 126.5, 123.4, 120.1, 55.5 (m) 
1-Methyl
, diphenyliodonium tetrafluoroborate (0.33 g, 0.90 mmol) and palladium(II) acetate( 6.0 mg, 5mol%) were combined in glacial acetic acid (4 mL) and stirred for 1h at 125 8 8Ci nt he microwave.T hereafter the cooled reaction mixture was filtered over celite,w ashed with dichloromethane (DCM,1 0mL) and concentrated under reduced pressure.T he residuew as dissolved in DCM (20 mL), washed with saturated sodiumb icarbonate and the organic layer was collected using a( hydrophobic frit) phase separator. Thes olution was concentrated under reduced pressure to yield an orangep roduct. Thec rude materialw as purifiedb yf lash chromatography (30 gC 18, acetonitrile: water, 30% to 90%) and the final product was obtained as aw hite powder;y ield:0 .083 g( 43%). 1 5, 143.0, 142.1, 140.8, 138.6, 131.2,1 30.5, 130.1, 130 
This was synthesised on a0 .31 mmols cale by the same procedure as 2a and bis (2- 3 Hz), 142.8, 139.7, 135.6, 131.5 (d, 3 J F, C = 3.1 Hz), 130. 8, 130.4, 129.9, 129.4, 129.1, 128.6 (d, 3 J F,C = 8.0 Hz), 128.5 (d, 2 J F, C = 16. 1 Hz), 128.4, 128.1, 123.4, 123.3( d, 4 
Thes ame procedure as 2a was used but bis(3-fluorophenyl)iodonium tetrafluoroborate (0.36 g, 0.90 mmol) was used instead of diphenyliodonium tetrafluoroborate.T he final product was obtained as aw hite powder;y ield:0 .111 g (54%). 1 3 J F, C = 11.9 Hz), 140. 5, 138.6, 132.1, 131.1, 130.4, 130.4 (d, 3 J F, C = 4.3 Hz), 130. 3, 129.4, 129.1, 128.3,1 25.0, 124.0, 121.1, 115.5 (d, 2 J F, C = 21. 8 Hz) , 114.0 (d, 2 J F, C = 20.9 Hz), 114. 1,5 6.6, 34.8; 19 FNMR ( 8, 141.9, 140.6, 139.1, 132.3, 131.2, 130.4, 130.6, 130 .0 (q, 2 J F, C = 29.9 Hz), 129. 9, 129.8, 129.1, 128.1, 127.9, 125.2 (q, 3 
1-
Thes ame procedurea s2a was used but bis(4-trifluoromethylphenyl)iodoniumt etrafluoroborate (0.45 g, 0.90 mmol) was used instead of diphenyliodonium tetrafluoroborate. Thef inal product was obtained as aw hite powder; yield: 0.104 g( 44%). 1 6, 169.2, 145.0, 143.1, 140.3, 139.2, 131.8, 131.0, 130.4, 130.2, 129.7, 129.5 (2 C), 128.9, 128.6, 127.6 (q, 2 J F, C = 31.6 Hz), 125.1 (q, 3 J F, C = 3.7 Hz, 2C), 124.6 (q, 1 J F, C = 272 Hz), 123. 9, 120.8, 56.9, 34.7; 19 Palladacycle (3) 5-Phenyl-1H-1,4-diazepin-2(3H)-one (0.20 g, 0.85 mmol) and sodium tetrachloropalladate (0.23 g, 0.78 mmol) were combined in ethanol (20 mL) for 48 ha tr oom temperature.T he orangep recipitate was filtereda nd washed with further ethanol (10 mL) and chloroform (10 mL). An orange solid powder was collected after drying under vacuum;y ield: 0.25 g( 69%).T he product was too insoluble for NMR analysis.
Thep roduct from above reaction (0.12 g, 0.33 mmol) and triphenylphosphine (0.08 g, 0.30 mmol) were combined in dichloromethane (10 mL)a nd stirredo vernight. Ther esulting unwanted precipitate was filtered through celite and the filtrate was concentrated under vacuum. Hexane was added to the concentrated crudep roduct to induce precipitation,t he precipitates was filtered and dried under vacuum. Thep roduct was obtained as ay ellow solid;y ield:0 .12 g( 63%). 
5-Phenyl-5-biphenyl-2-yl-1,3-dihydro-2H-1,4benzodiazepin-2-one (4a)
5-Phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (0.14 g, 0.59 mmol), diphenyliodonium tetrafluoroborate (0.33 g, 0.90 mmol) and palladium (II)a cetate (6.0 mg, 5mol%) were combined in degassed glacial acetic acid (4 mL) and stirredf or 1hat 125 8 8C. Thereafter the cooled reaction mixture was filteredo ver celite,w ashed with DCM (10 mL) and concentrated under reducedp ressure.T he residuew as dissolvedi nD CM (20 mL), washed with saturated sodium bicarbonate and the organic layer was collectedusing a(hydrophobicf rit) phase separator. Thes olution was concentrated under reduced pressuret oy ield an orangep roduct.T he crude material was purified by flash chromatography (30 g C18, acetonitrile:w ater, 30% to 90%). Starting material, 5phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one was recovered (0.031 g, 0.13 mmol) and the final product was obtained as aw hite powder; yield:0 .079 g( 56%). 1 3, 169.7, 141.5, 140.5, 139.8, 139.2, 131.3, 130.9, 130.2, 130.1, 129 .4,1 28.6 (2 C), 128.3, 128.0 (2 C), 127. 6, 127.1, 122.6, 120.7, 57.3 
5-
Thes ame methoda s4a was used but bis(2-fluorophenyl)iodoniumt etrafluoroborate (0.36 g, 0.90 mmol) was used instead of diphenyliodonium tetrafluoroborate.S tartingm aterial, 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one, was recovered (0.021 g, 0.09 mmol) and the final product was obtained as aw hite powder;y ield:0 .114 g( 69%). 1 9, 174.6, 163.4 (d, 1 J F, C = 247. 3 Hz), 145.3, 143.8, 140.3, 136.2 (d, 4 J F,C = 3.2 Hz), 136. 1, 135.8, 135.4, 134.5, 134.4 (t, 3 J F, C = 4.1 Hz), 133. 1, 132.9 (d, 2 J F, C = 15.6 Hz), 132.7,1 28.9 (d, 3 J F,C = 3.5 Hz), 127.4, 125.5, 120.1, 120.0 (d, 2 
5-(3' '-Fluorobiphenyl-2-yl)-1,3-dihydro-2H-1,4benzodiazepin-2-one (4c)
Thes ame methoda s4a was used but bis(3-fluorophenyl)iodoniumt etrafluoroborate (0.36 g, 0.90 mmol) was used instead of diphenyliodonium tetrafluoroborate.S tartingm aterial, 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one was recovered (0.045 g,0.19 mmol) and the final product was obtained as aw hite powder;y ield:0 .095 g( 72%). 1 2, 139.8, 139.3, 131.5, 130.9, 130.2, 130.1, 129.9 (d, 3 J F, C = 8.4 Hz), 129.5, 128.2, 128.1, 124.9, 122.7, 120.6, 115.3 (d, 2 
5-(3' '-Trifluoromethylbiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (4d)
Thes ame method as 4a was used but bis (3-trifluoromethylphenyl) iodonium tetrafluoroborate (0.45 g, 0.90 mmol) was used insteadofdiphenyliodonium tetrafluoroborate.Starting material, 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one, was recovered (0.022 g, 0.09 mmol) andt he final product was obtained as aw hite powder;y ield:0 .119 g( 63%). 1 HNMR (500 MHz, DMSO-d 6 ): d = 10.22 (s, 1H), 3H), 7.42( d, J = 7.9 Hz, 1H), 7.38 (dd, J = 7.4, 1.5 Hz, 1H), 7.34 (pt, J = 7.9 Hz, 1H), 3H), 2H), 6.75 (dd, J = 8.2, 1.5 Hz, 1H) , 4.03 (s,2 H); 13 CNMR (126 MHz, DMSO-d 6 : d = 171.7,1 69.8, 141.6, 140.1, 139.9, 139.2, 132.6, 131.5, 130.9, 130.2 (2C), 129.6, 129.1, 129 .0 (q, 2 J F, C = 31. 8 Hz), 128.4, 128.0, 125.0 (q, 3 J F, C = 3.7 Hz), 124.3 (q, 1 J F, C = 272.6 Hz), 123.8 (q, 3 J F, C = 3.7 Hz), 122. 6, 120.6,5 7.4; 19 
5-
Thes ame method as 4a was used but bis(4-trifluoromethylphenyl)iodonium tetrafluoroborate (0.45 g, 0.90 mmol) was used insteadofdiphenyliodonium tetrafluoroborate.Starting material, 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one, was recovered (0.036 g, 0.15 mmol) andt he final product was obtained as aw hite powder;y ield:0 .097 g( 58%). 7, 169.9, 144.6, 140.1, 139.7, 139.3, 131.5, 131.2, 130.4, 130.3, 129.5, 129.4 (2C), 128.5, 128.1, 127.7 (q, 2 J F, C = 31.6 Hz), 124.9 (q, 3 J F,C = 4.1 Hz,2 C), 124.6 (q, 1 J F, C = 272. 8 Hz), 122.8, 120.6, 57.3; 19 FNMR (376 MHz, DMSO- 
5-(4'
Thes ame method as 4a was used but 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (0.095 g, 0.40 mmol) and bis(4methoxyphenyl)iodonium tetrafluoroborate (0.26 g, 0.60 mmol) were used instead of diphenyliodonium tetrafluoroborate.Startingm aterial, 5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one was recovered (0.016 g, 0.07 mmol) and the final product wasobtained as awhite powder; yield: 0.039 g( 35%). 1 2, 170.5, 158.6, 141.6, 137.3, 133.3, 131.2, 130.0, 130.1, 129.9, 129.8 (2C), 129.7, 129.6, 127.0, 123.2, 120.0, 113.1 3-Benzyl-5-(2' '-fluorobiphenyl-2-yl) -1,3-dihydro-2H-1,4-benzodiazepin-2-one (4g) Thes amem ethoda s4a was used but 3-benzyl-5-phenyl-1,3dihydro-2H-1,4-benzodiazepin-2-one (0.17 g, 0.52 mmol) instead of 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one, and bis(2-fluorophenyl)iodonium tetrafluoroborate (0.29 g, 0.78 mmol) were used instead of diphenyliodonium tetrafluoroborate and the reactionw as carried out at 150 8 8C. The final product was obtained as aw hite powder;y ield:0 .090 g (41%). 1 HNMR (500 MHz, CDCl 3 ): d = 7.83 (s, 1H), 3H), 5H), 7H), 6.73 (pt, J = 9.1 Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 2H), 1H) ; 13 CNMR (126 MHz, CDCl 3 ): d = 170. 3, 170.1, 158.8 (d, 1 J F, C = 247. 1 Hz), 139.9, 1 39.2, 136.8, 135.8, 131.7, 131.2, 130.8, 130.5, 129.9, 129.8 (2 C), 129.5, 128.9 (d, 3 J F, C = 8.2 Hz), 128.5 (d, 3 J F, C = 4.0 Hz), 128.4, 128.3, 128.2 (2 C), 128.1, 126.1, 123.3, 120.0, 114.9 (d, 2 J F, C = 21. 8 Hz), 64.8, 37.4; 19 FNMR (376 MHz, 
5-
Thes ame method as 4a was used but 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (0.100 g, 0.42 mmol) and (3methylphenyl) (2,4,6-trimethylphenyl) iodonium triflate (0.31 g, 0.62 mmol) were used insteado fd iphenyliodonium tetrafluoroborate.S tarting material, 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one was recovered (0.012 g, 0.05 mmol) and the final product was obtained as aw hite powder;y ield:0 .070 g( 58%). 1 HNMR (500 MHz, CDCl 3 ): d = 8.41 (s, 1H), 7.71 (dd, J = 8.0, 1.9 Hz, 1H), 2H), 1H), 1H), 1H), 3H), 2H) 2, 170.7, 142.2,1 40.6, 139.6, 137.4, 137.1, 131.0, 129.9, 129.8, 129.7, 129.6, 129.5, 128.8, 127.4, 127.3, 127.2, 125.8,1 23.0, 119.9, 56.4, 21.1; H R-MS-ESI: m/z = 327.1483, calculated for C 22 5.56, N8 .5; found:C80.93, H5.42, 5-Chloro-2-aminobenzophenone (0.621 g, 3.15 mmol), N-(3dimethylaminpropyl)-N-ethylcarbodiimideh ydrochloride (0.604 g, 3.15 mmol) and N-Boc-glycine (0.550 g, 3.15 mmol) were combined in toluene( 6mL) and irradiated in the microwave for 30 min at 150 8 8C. Tr ifluoroacetic acid (2 mL) was then added to the mixture and it was irradiatedfor afurther 20 min at 150 8 8C. Thec ooled solution was neutralized by an aqueous3 NN aOH solution( 50 mL) and extracted with dichloromethane (3 30mL). Theo rganic layers were dried over MgSO 4 and evaporated.T he crude materialw as purified by column chromatography (ethyl acetate:DCM, 10% to 40%) and the final product was obtained as aw hite powder;0 .29 g( 34%). 1 = 7.5 Hz, 2H), 7.30 (d, J = 2.4 Hz, 1H), 7.14 (d, J = 8.6 Hz, 1H) , 4.33 (s,2 H); 13 CNMR (126 MHz, CDCl 3 ): d = 171. 7, 169.8, 138.7, 137.3,1 31.8, 130.7, 130.6, 129.6 (2 C), 128.9, 128.5, 128.4 (2 C), 122.6,5 6.5 
7-Chloro
Thes ame method as 4a was used but 7-chloro-5-phenyl-1,3dihydro-2H-1,4-benzodiazepin-2-one (0.16 g, 0.6 mmol) was used instead of 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one.S tarting material, 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one,w as recovered (0.010 g, 0.04 mmol) and the final product wasobtained as awhite powder;yield: 0.118 g( 61%). 1 8, 169.4, 141.6 140.5, 139.0, 138.2, 131.2, 131.1,1 30.5, 130.3, 129.6, 128.5 (2 C), 128.4, 128.2 (2 C), 127.8,1 27.2, 126.4, 122.7, 57.4 
Thes ame methoda sf or 5a was used but (4-nitrophenyl)- (2,4,6-trimethylphenyl) iodonium triflate (0.47 g, 0.9 mmol) was usedi nstead of of diphenylliodonium tetrafluoroborate. Starting material, 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one recovered (0.040 g, 0.15 mmol) and the final product was obtained as aw hite powder;y ield:0 .099 g (55%). 1 1, 169.4, 144.6, 140.1, 139.6, 139.1, 138.1, 131.5, 131.1, 130.7, 130.1, 129.9, 129.7, 129.1, 128.6, 126.7, 125.4, 124.9, 123.8, 122.6, 57.4 7-Chloro-5-(2' '-fluorobiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (5c) Thes ame methoda s5a was used but bis(2-fluoropheny)liodoniumt etrafluoroborate( 0.36 g, 0.9 mmol) was used instead of diphenylliodonium tetrafluoroborate.Startingmaterial, 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2one,w as recovered (0.010 g, 0.04 mmol), the final product as aw hite powder;y ield:0 .13 g( 64%) and the diarylated product 5c' ' wasc ollected as aw hite powder;y ield:0 .026 g (10%). 1 HNMR (500 MHz, DMSO-d 6 : d = 10.37 (s,1 H), 7.66-7.61 (m, 1H), 7.59-7.54 (m, 2H), 7.34 (d, J = 7.3 Hz, 1H), 7.31-7.23 (m, 1H), 7.21-7.11 (m, 1H), 6.97 (pt, J = 7.5 Hz, 1H), 6.91 (d, J = 9.5 Hz, 1H), 6.87 (dd, J = 6.8 Hz, 3 J F, H = 8.6 Hz, 1H), 6.82 (d, J = 8.6Hz, 1H), 6.76 (d, J = 2.5 Hz, 1H) , 4.03 (s,2H); 13 CNMR (126 MHz, DMSO-d 6 ): d = 169. 8, 169.5, 158.7 (d, 1 J F,C = 244. 8 Hz), 139.82, 138.1, 135.5, 131.4, 131.2, 131.1, 130.9, 130.2, 129.8 (d, 3 J F, C = 8.0 Hz), 129. 6, 129.2,1 28.6 (d, 3 J F, C = 9.8 Hz), 128.0 (d, 2 J F, C = 15.6 Hz), 126. 6,1 24.3 (d, 4 9, 136.4, 131.9, 131.8, 131.1 (2 C) , 131.0 (2 C), 129.9 (d, 3 J F, C = 8. 1 Hz, 2C), 129.5, 129.3, 128.5, 128.3, 1 28.2, 126.5, 124.3 (d, 4 J F, C = 3.5 Hz, 2C), 122. 6,1 15.4 (d, 2 7-Chloro-5-(4' '-trifluorobiphenyl-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (5d) Thes ame methoda s5a was used but diphenyliodonium tetrafluoroborate (0.45 g, 0.9 mmol) was used instead of diphenyliodonium tetrafluoroborate and the reactiont emperature was 145 8 8C. Starting material, 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one,w as recovered (0.020 g, 0.066 mmol) and the final product 5d was obtained as aw hite powder; yield:0 .053 g( 24%). Thed iarylated product 5d' ' was collecteda sabrown powder;y ield:0 .045 g (15%). 1 
